Vitamin C enhances nanog expression via activation of the JAK/STAT signaling pathway

Stem Cells

Volumn 32, Issue 1, 2014, Pages 166-176

  Wu, Haibo ^a,b   Wu, Yongyan ^a,b   Ai, Zhiying ^b,c   Yang, Liping ^b,c   Gao, Yuan ^b,c   Du, Juan ^b,c   Guo, Zekun ^a,b   Zhang, Yong ^a,b  

^a Institution of biotechnology   (China)

^b AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^c NORTHWEST A F UNIVERSITY   (China)

Author keywords

Embryonic stem cells; Nanog; Pluripotent stem cells; Signaling pathway; Transcription factors; Vitamin C

Indexed keywords

ASCORBIC ACID; JANUS KINASE; RETINOIC ACID; STAT2 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; IN VITRO STUDY; MOUSE; MUTATION; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

EMBRYONIC STEM CELLS; NANOG; PLURIPOTENT STEM CELLS; SIGNALING PATHWAY; TRANSCRIPTION FACTORS; VITAMIN C;

ANIMALS; ASCORBIC ACID; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELLS, CULTURED; EMBRYONAL CARCINOMA STEM CELLS; EMBRYONIC STEM CELLS; HOMEODOMAIN PROTEINS; JANUS KINASES; MICE; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; STAT2 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 84891772569     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1523     Document Type: Article

References (38)

1. Chambers I, Colby D, Robertson M et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003;113:643-655.
2. Mitsui K, Tokuzawa Y, Itoh H et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003;113:631-642.
3. Cavaleri F, Scholer HR. Nanog: A new recruit to the embryonic stem cell orchestra. Cell 2003;113:551-552.
4. Dravid G, Ye Z, Hammond H et al. Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells 2005;23:1489-1501.
5. Kuroda T, Tada M, Kubota H et al. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 2005;25:2475-2485.
6. Rodda DJ, Chew JL, Lim LH et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 2005;280:24731-24737.
7. Pan G, Li J, Zhou Y et al. A negative feedback loop of transcription factors that controls stem cell pluripotency and selfrenewal. FASEB J 2006;20:1730-1732.
8. Jiang J, Chan YS, Loh YH et al. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 2008;10:353-360.
9. Suzuki A, Raya A, Kawakami Y et al. Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells. Proc Natl Acad Sci USA 2006;103:10294-10299.
10. Liang J, Wan M, Zhang Y et al. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat Cell Biol 2008;10:731-739.
11. Kisseleva T, Bhattacharya S, Braunstein J et al. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 2002;285:1-24.
12. Romero-Weaver AL, Wang HW, Steen HC et al. Resistance to IFN-alpha-induced apoptosis is linked to a loss of STAT2. Mol Cancer Res 2010;8:80-92.
13. Testoni B, Schinzari V, Guerrieri F et al. p53-paralog DNp73 oncogene is repressed by IFNalpha/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor. Oncogene 2011;30:2670-2678.
14. Gao Y, Cimica V, Reich NC. Suppressor of cytokine signaling 3 inhibits breast tumor kinase activation of STAT3. J Biol Chem 2012; 287:20904-20912.
15. Matthews JR, Sansom OJ, Clarke AR. Absolute requirement for STAT3 function in small-intestine crypt stem cell survival. Cell Death Differ 2011;18:1934-1943.
16. Martinez A, Varade J, Marquez A et al. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. Arthritis Rheum 2008;58:2598-2602.
17. Wierenga AT, Vellenga E, Schuringa JJ. Down-regulation of GATA1 uncouples STAT5-induced erythroid differentiation from stem/ progenitor cell proliferation. Blood 2010;115: 4367-4376.
18. De TMC. Beyond the antioxidant: The double life of vitamin C. Subcell Biochem 2012;56:49-65.
19. Esteban MA, Wang T, Qin B et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010;6:71-79.
20. Pfaffl MW. A new mathematical model for relative quantification in real-time RTPCR. Nucleic Acids Res 2001;29:e45.
21. Wu Y, Guo Z, Wu H et al. SUMOylation represses nanog expression via modulating transcription factors Oct4 and Sox2. PLoS One 2012;7:e39606.
22. Chen H, Sun H, You F et al. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 2011;147:436-446.
23. Goenka S, Kaplan MH. Transcriptional regulation by STAT6. Immunol Res 2011;50: 87-96.
24. Messeguer X, Escudero R, Farre D et al. PROMO: Detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 2002;18:333-334.
25. Farre D, Roset R, Huerta M et al. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res 2003;31:3651-3653.
26. Niwa H, Burdon T, Chambers I et al. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 1998;12:2048-2060.
27. Cartwright P, McLean C, Sheppard A et al. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 2005;132:885-896.
28. Alonso A, Breuer B, Steuer B et al. The F9-EC cell line as a model for the analysis of differentiation[J]. Int J Dev Biol 1991;35:389-397.
29. Martin GR. Teratocarcinomas and mammalian embryogenesis. Science 1980;209: 768-776.
30. Lehtonen E, Laasonen A, Tienari J. Teratocarcinoma stem cells as a model for differentiation in the mouse embryo[J]. Int J Dev Biol 1989;33:105.
31. Choi HI, Park JI, Kim HJ et al. A novel Lascorbic acid and peptide conjugate with increased stability and collagen biosynthesis. BMB Rep 2009;42:743-746.
32. Qiao H, Bell J, Juliao S et al. Ascorbic acid uptake and regulation of type I collagen synthesis in cultured vascular smooth muscle cells. J Vasc Res 2009;46:15-24.
33. Fukumura H, Sato M, Kezuka K et al. Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells. J Physiol Sci 2012;62:251-257.
34. Kim JE, Cho HS, Yang HS et al. Depletion of ascorbic acid impairs NK cell activity against ovarian cancer in a mouse model. Immunobiology 2012;217:873-881.
35. Ohno S, Ohno Y, Suzuki N et al. Highdose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer. Anticancer Res 2009;29:809-815.
36. Wei FL, Qu CY, Song TL et al. Vitamin C treatment promotes mesenchymal stem cell sheet formation and tissue regeneration by elevating telomerase activity. J Cell Physiol 2012;227:3216-3224.
37. Huang Y, Tang X, Xie W et al. Vitamin C enhances in vitro and in vivo development of porcine somatic cell nuclear transfer embryos. Biochem Biophys Res Commun 2011;411:397-401.
38. Wang T, Chen K, Zeng X et al. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-Cdependent manner. Cell Stem Cell 2011;9: 575-587.